Clinical trial for effects of French maritime pine bark/bilberry fruit extracts on intraocular pressure for primary open angle glaucoma

Tanito Masaki0 个研究点目标入组 24 人开始时间: 2023年8月21日最近更新: 2023年10月17日

试验速览

暂无简介。

•1) Primary open-angle glaucoma including juvenile open-angle glaucoma and normal tension glaucoma or ocular hypertension in one or both eyes.
•2) Glaucoma progression and ocular hypertension are controlled with no medication or three or fewer medications.
•3) No need for eye surgery, including glaucoma, within the next 12 months in either eye.
•4) At least one eye has an intraocular pressure of 15 mmHg or greater by Goldmann applanation tonometer under the use of glaucoma medication.
•5) Self-measurement of intraocular pressure and blood pressure is possible.
•6) Written informed consent.

•1) Severe systemic illness.
•2) Secondary glaucoma.
•3) Other eye diseases leading to blindness, except glaucoma and mild cataracts.
•4) Hepatic, renal, and cardiac disorders affecting assessment.
•5) May cause allergic reactions to the test food.
•6) May cause severe allergic reactions to other foods and medicines.
•7) Continuous intake habits of antioxidant advocacy supplements (pine bark extract, bilberry, blackcurrant, lutein, astaxanthin, vitamin C, and vitamin E) in the 6 months before enrolment or planned to do so during the study period.
•8) Lifestyle changes may be made during the study period (e.g. extended travel, change of diet).
•9) Pregnant, lactating, or possibly pregnant.
•10) Participation in another human clinical trial at the time of consent.

发起方

Tanito Masaki